The year ahead looks particularly exciting for BIOTA Holdings Ltd., because: [1] New long acting flu drug (LANI) developments progress with Sankyo Japan.
[2] Positive outcome of suit against Glaxo GSK.
[3] Expectation of vicious influenza pandemic in near future!
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.